Trial no.:
|
PACTR202407873710427 |
Date of Approval:
|
22/07/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Comparative Impact of Sleeve Gastrectomy and One Anastomosis Gastric Bypass on Glycemic Control and Abdominal Adiposity: A Randomized Controlled Study
|
Official scientific title |
Comparative Impact of Sleeve Gastrectomy and One Anastomosis Gastric Bypass on Glycemic Control and Abdominal Adiposity: A Randomized Controlled Study
|
Brief summary describing the background
and objectives of the trial
|
It has been presumed that both abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) depots are considered a crucial part of the endocrine system, which is implicated in the multifaceted interplay among obesity, metabolic complications, and systemic inflammation. Both fat depots, along with intrahepatic fat, have been described to be involved in metabolic complications through the secretion of bioactive cytokines, leading to resistance to insulin and subsequent type 2 DM.
We aim to study the effect of sleeve gastrectomy and one anastomosis gastric bypass in the loss of visceral fat and correlate the effect of fat loss on the control of diabetes mellitus in both surgeries. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
01/09/2022 |
Actual trial start date |
21/09/2022 |
Anticipated date of last follow up |
06/02/2024 |
Actual Last follow-up date |
22/02/2024 |
Anticipated target sample size (number of participants) |
80 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Completed |
Publication URL |
|
|